EVAX — Evaxion Biotech A/S Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapMomentum Trap

Annual balance sheet for Evaxion Biotech A/S, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	PROSPECTUS	20-F	20-F	20-F	20-F
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Short Term Investments	9.56	5.83	32.2	13.2	5.58
Net Total Accounts Receivable
Net Total Receivables	0.948	2.21	1.34	1.09	1.07
Prepaid Expenses
Total Other Current Assets
Total Current Assets	11	10.9	34.7	17	8.35
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.101	0.221	5.17	4.67	4.34
Net Intangible Assets
Long Term Notes Receivable
Other Long Term Assets
Total Assets	11.1	12	40.2	22	12.9
Accounts Payable
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	1.72	4.93	4.32	3.76	7.08
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	1.72	4.93	7.73	13.7	17.6
Common Stock
Retained Earnings (Accumulated Deficit)
Total Equity	9.36	7.04	32.4	8.3	-4.73
Total Liabilities & Shareholders' Equity	11.1	12	40.2	22	12.9
Total Common Shares Outstanding